Subjects -> MEDICAL SCIENCES (Total: 8196 journals)
    - ANAESTHESIOLOGY (105 journals)
    - CARDIOVASCULAR DISEASES (334 journals)
    - DENTISTRY (266 journals)
    - ENDOCRINOLOGY (149 journals)
    - FORENSIC SCIENCES (43 journals)
    - HEMATOLOGY (160 journals)
    - HYPNOSIS (4 journals)
    - INTERNAL MEDICINE (177 journals)
    - MEDICAL GENETICS (58 journals)
    - MEDICAL SCIENCES (2241 journals)
    - NURSES AND NURSING (331 journals)
    - OBSTETRICS AND GYNECOLOGY (199 journals)
    - ONCOLOGY (355 journals)
    - OTORHINOLARYNGOLOGY (76 journals)
    - PATHOLOGY (96 journals)
    - PEDIATRICS (254 journals)
    - PSYCHIATRY AND NEUROLOGY (800 journals)
    - RESPIRATORY DISEASES (109 journals)
    - RHEUMATOLOGY (76 journals)
    - SPORTS MEDICINE (77 journals)
    - SURGERY (388 journals)

UROLOGY, NEPHROLOGY AND ANDROLOGY (151 journals)                     

Showing 1 - 144 of 144 Journals sorted alphabetically
Actas Urológicas Españolas     Full-text available via subscription   (Followers: 1)
Actas Urológicas Españolas (English Edition)     Full-text available via subscription   (Followers: 1)
Advances in Chronic Kidney Disease     Hybrid Journal   (Followers: 15)
Advances in Urology     Open Access   (Followers: 13)
African Journal of Nephrology     Open Access   (Followers: 1)
African Journal of Urology     Open Access   (Followers: 8)
AJP Renal Physiology     Hybrid Journal   (Followers: 8)
Aktuelle Urologie     Hybrid Journal   (Followers: 4)
American Journal of Kidney Diseases     Hybrid Journal   (Followers: 53)
American Journal of Men's Health     Open Access   (Followers: 9)
American Journal of Nephrology     Full-text available via subscription   (Followers: 31)
Andrologia     Hybrid Journal   (Followers: 3)
Andrology     Hybrid Journal   (Followers: 4)
Andrology & Gynecology : Current Research     Hybrid Journal   (Followers: 4)
Andrology and Genital Surgery     Open Access   (Followers: 8)
Arab Journal of Nephrology and Transplantation     Open Access   (Followers: 2)
Arab Journal of Urology     Open Access   (Followers: 7)
Archives of Clinical Nephrology     Open Access   (Followers: 2)
Archivio Italiano di Urologia e Andrologia     Open Access   (Followers: 1)
Archivos Españoles de Urología     Open Access   (Followers: 1)
Asian Journal of Andrology     Open Access   (Followers: 1)
Asian Journal of Urology     Open Access   (Followers: 3)
Asian Pediatric Nephrology Association     Open Access   (Followers: 3)
Bangladesh Journal of Urology     Open Access   (Followers: 5)
Basic and Clinical Andrology     Open Access  
BJU International     Hybrid Journal   (Followers: 19)
BJUI Compass     Open Access   (Followers: 1)
BMC Nephrology     Open Access   (Followers: 9)
BMC Urology     Open Access   (Followers: 13)
Canadian Journal of Kidney Health and Disease     Open Access   (Followers: 7)
Canadian Urological Association Journal     Open Access   (Followers: 1)
Cancer Urology     Open Access   (Followers: 1)
Cardiorenal Medicine     Full-text available via subscription   (Followers: 1)
Case Reports in Nephrology     Open Access   (Followers: 6)
Case Reports in Nephrology and Dialysis     Open Access   (Followers: 7)
Case Reports in Urology     Open Access   (Followers: 11)
Clinical and Experimental Nephrology     Hybrid Journal   (Followers: 5)
Clinical Journal of the American Society of Nephrology     Full-text available via subscription   (Followers: 24)
Clinical Kidney Journal     Open Access   (Followers: 5)
Clinical Medicine Insights : Urology     Open Access   (Followers: 3)
Clinical Nephrology     Full-text available via subscription   (Followers: 8)
Cuadernos de Cirugía     Open Access  
Current Opinion in Nephrology & Hypertension     Hybrid Journal   (Followers: 12)
Current Opinion in Urology     Hybrid Journal   (Followers: 11)
Current Urology     Open Access   (Followers: 10)
Current Urology Reports     Hybrid Journal   (Followers: 5)
Der Nephrologe     Hybrid Journal  
Der Urologe     Hybrid Journal   (Followers: 1)
Diabetic Nephropathy     Open Access  
EMC - Urología     Full-text available via subscription  
Enfermería Nefrológica     Open Access   (Followers: 1)
European Urology     Hybrid Journal   (Followers: 22)
European Urology Focus     Hybrid Journal   (Followers: 3)
European Urology Oncology     Hybrid Journal  
European Urology Open Science     Open Access   (Followers: 8)
Forum Nefrologiczne     Full-text available via subscription  
Geriatric Nephrology and Urology     Hybrid Journal   (Followers: 7)
Giornale di Clinica Nefrologica e Dialisi     Open Access  
Hellenic Urology     Open Access   (Followers: 4)
IJU Case Reports     Open Access  
Indian Journal of Nephrology     Open Access   (Followers: 2)
Indian Journal of Urology     Open Access   (Followers: 5)
International Brazilian Journal of Urology     Open Access   (Followers: 5)
International Journal of Nephrology     Open Access   (Followers: 2)
International Journal of Nephrology and Renovascular Disease     Open Access   (Followers: 2)
International Journal of Urology     Hybrid Journal   (Followers: 10)
International Urology and Nephrology     Hybrid Journal   (Followers: 6)
Journal für Urologie und Urogynäkologie/Österreich     Hybrid Journal  
Journal of Clinical Nephrology     Open Access   (Followers: 1)
Journal of Clinical Urology     Hybrid Journal   (Followers: 12)
Journal of Endoluminal Endourology     Open Access  
Journal of Endourology     Hybrid Journal   (Followers: 2)
Journal of Endourology Case Reports     Hybrid Journal  
Journal of Genital System & Disorders     Hybrid Journal   (Followers: 1)
Journal of Integrative Nephrology and Andrology     Open Access   (Followers: 2)
Journal of Kidney Cancer and VHL     Open Access  
Journal of Lower Genital Tract Disease     Hybrid Journal  
Journal of Nephrology     Hybrid Journal   (Followers: 5)
Journal of Nephrology Research     Open Access   (Followers: 2)
Journal of Pediatric Nephrology     Open Access   (Followers: 3)
Journal of Renal Care     Hybrid Journal   (Followers: 8)
Journal of Renal Nursing     Full-text available via subscription   (Followers: 8)
Journal of Renal Nutrition     Hybrid Journal   (Followers: 28)
Journal of Renal Nutrition and Metabolism     Open Access   (Followers: 2)
Journal of the American Society of Nephrology     Full-text available via subscription   (Followers: 38)
Journal of The Egyptian Society of Nephrology and Transplantation     Open Access  
Journal of Urology & Nephrology     Open Access  
Kidney Diseases     Open Access   (Followers: 3)
Kidney International     Hybrid Journal   (Followers: 52)
Kidney International Reports     Open Access   (Followers: 6)
Kidney Medicine     Open Access   (Followers: 1)
Kidney Research Journal     Open Access   (Followers: 6)
Kidneys (Počki)     Open Access  
Nature Reviews Nephrology     Full-text available via subscription   (Followers: 29)
Nature Reviews Urology     Full-text available via subscription   (Followers: 9)
Nefrología     Open Access  
Nefrología (English Edition)     Open Access  
Nephro-Urology Monthly     Open Access   (Followers: 1)
Nephrology     Hybrid Journal   (Followers: 13)
Nephrology Dialysis Transplantation     Hybrid Journal   (Followers: 26)
Nephron     Hybrid Journal   (Followers: 4)
Nephron Clinical Practice     Full-text available via subscription   (Followers: 3)
Nephron Experimental Nephrology     Full-text available via subscription   (Followers: 4)
Nephron Extra     Open Access   (Followers: 1)
Nephron Physiology     Full-text available via subscription   (Followers: 4)
Neurourology and Urodynamics     Hybrid Journal   (Followers: 1)
OA Nephrology     Open Access   (Followers: 2)
Open Access Journal of Urology     Open Access   (Followers: 6)
Open Journal of Nephrology     Open Access   (Followers: 4)
Open Journal of Urology     Open Access   (Followers: 6)
Open Urology & Nephrology Journal     Open Access  
Paediatric Nephrology Journal of Bangladesh     Open Access   (Followers: 4)
Portuguese Journal of Nephrology & Hypertension     Open Access   (Followers: 1)
Progrès en Urologie     Full-text available via subscription  
Progrès en Urologie - FMC     Full-text available via subscription  
Prostate Cancer and Prostatic Diseases     Hybrid Journal   (Followers: 4)
Renal Failure     Open Access   (Followers: 11)
Renal Replacement Therapy     Open Access   (Followers: 3)
Research and Reports in Urology     Open Access   (Followers: 4)
Revista de Nefrología, Diálisis y Trasplante     Open Access   (Followers: 1)
Revista Mexicana de Urología     Open Access  
Revista Urologia Colombiana     Open Access  
Scandinavian Journal of Urology     Hybrid Journal   (Followers: 6)
Seminars in Nephrology     Hybrid Journal   (Followers: 11)
The Prostate     Hybrid Journal   (Followers: 6)
Therapeutic Advances in Urology     Open Access   (Followers: 3)
Translational Research in Urology     Open Access   (Followers: 1)
Trends in Urology & Men's Health     Partially Free   (Followers: 1)
Urine     Open Access  
Uro-News     Hybrid Journal  
Urolithiasis     Hybrid Journal   (Followers: 1)
Urologia Internationalis     Full-text available via subscription   (Followers: 1)
Urologia Journal     Hybrid Journal  
Urologic Clinics of North America     Full-text available via subscription   (Followers: 3)
Urologic Nursing     Full-text available via subscription   (Followers: 3)
Urological Science     Open Access  
Urologicheskie Vedomosti     Open Access  
Urologie in der Praxis     Hybrid Journal  
Urology     Hybrid Journal   (Followers: 26)
Urology Case Reports     Open Access   (Followers: 3)
Urology Times     Free   (Followers: 3)
Urology Video Journal     Open Access  
World Journal of Nephrology and Urology     Open Access   (Followers: 5)
World Journal of Urology     Hybrid Journal   (Followers: 10)


Similar Journals
Journal Cover
African Journal of Nephrology
Number of Followers: 1  

  This is an Open Access Journal Open Access journal
ISSN (Print) 2306-8205 - ISSN (Online) 2518-4601
Published by Stellenbosch University Homepage  [12 journals]
  • Editorial note: Welcome to the year 2022 and Volume 25

    • Authors: Alain G Assounga
      Pages: 1 - 1
      Abstract: The Editorial Board and Editors of the African Journal of Nephrology wish all authors, reviewers and readers a very happy and blessed New Year. Like the last two years, we start this year in a wave of the COVID-19 pandemic. Hopefully, the future waves will be less and less severe and deadly. Given the significant protection against severe forms of disease provided by COVID vaccines, we urge everyone to get vaccinated. We are proud to announce that the African Journal of Nephrology is 25 years old this year. From its humble beginnings in 1997 when the founding editor-in-chief, the late Prof Maher Ramzy of Egypt, published the first i ssue, the Journal has persevered for 25 years and is now an established online publication and a member of the Directory of Open Access Journals. In 2021, the African nephrology calendar included the African Association of Nephrology (AFRAN) congress in Abidjan, Côte D’Ivoire, in December 2021. The pre-congress workshops included a workshop on research methodology organized with the collaboration of the ERA-EDTA Registry and the African Journal of Nephrology. The congress was successful despite the challenges of the pandemic, showcasing research from the continent. The proceedings will be published in volume 25 of the Journal. To commemorate our 25th year, we will continue with the African nephrology legacy project to document the history of nephrology in Africa. This volume will feature the history of nephrology in South Africa. The first publication of the African nephrology legacy project covered the history of AFRAN [1] and was published in 2017, authored by Prof Rashad Barsoum, the first AFRAN president. This year also marks the 10th anniversary of my tenure as Editor-in-Chief of the Journal. I am proud and honoured to have led the Journal for a decade. I wish to thank everyone who made it possible, including authors, reviewers and especially the editorial team including Deputy Editor Prof Razeen Davids, Associate Editors Prof Fergus Caskey, Prof Sarala Naicker and Prof Faiçal Jarraya, and Editorial Fellows Drs Yazied Chothia, Elliot Tannor and Vincent Boima. My thanks also goes to the secretarial team including Yolisa Mncundza, Jane John, Lethisha Harilall and the Turners Secretariat, the production team including Reach Publishers, Graham Baker and Ilze de Kock, Stellenbosch University for hosting the Journal, and the University of KwaZulu-Natal for supporting my efforts to lead the Journal and contribute to the  promotion of African scholarship. Finally, in 2022, the South African Renal Congress will be held in Durban from 26–29 May and I invite you all to join us. Once again, Happy 25th Anniversary to the African Journal of Nephrology! Alain G Assounga
      PubDate: 2022-02-01
      Issue No: Vol. 25, No. 1 (2022)
  • Acknowledgement to reviewers 2020 and 2021

    • Authors: M Razeen Davids
      Pages: 2 - 2
      Abstract: The editors of AJN wish to thank the colleagues who generously gave of their time and expertise to review manuscripts for us during 2020 and 2021. We greatly appreciate their contribution to the quality of the work that we publish.
      PubDate: 2022-02-01
      Issue No: Vol. 25, No. 1 (2022)
  • Early mortality in patients with kidney failure starting chronic dialysis
           in Zambia: a retrospective cohort analysis

    • Authors: Justor Banda, Tela Bulaya, Aggrey Mweemba, Morgan Mweene, Nambaya Suwilanji, Chenga Natasha, Seter Siziya
      Pages: 3 - 7
      Abstract: Introduction: Dialysis is the primary kidney replacement therapy for patients with kidney failure in sub-Saharan Africa. We assessed the rates and predictors of early mortality in Zambian patients starting chronic dialysis. Methods: This retrospective study included all patients who started chronic haemodialysis (HD) or peritoneal
      dialysis (PD) between 1 January 2017 and 31 August 2020 at the three largest public dialysis centres in Zambia. Data on clinical, laboratory and dialysis characteristics were extracted from medical records. The primary outcome of interest was the mortality rate at 90 days. Results: A total of 154 patients were included in the study; 43.5% were female and 32% were 50 years or older.
      The main causes of kidney failure were hypertension (59%), glomerulonephritis (10%), HIV/AIDS (10%) and
      unknown (8%). The mortality rate at 90 days was 12.3%. Of these, 42% were cardiovascular-related mortalities and 32% died of infection related to central venous catheters. The lymphocyte percentage of total white blood cells was lower in patients who died compared to survivors (12.7 vs 20.8%) and was an independent predictor of early mortality (OR 0.914, 95% CI 0.850–0.983; P = 0.015). Conclusions: Early mortality was high in Zambian patients starting dialysis, and a low lymphocyte percentage was a predictor of mortality.
      PubDate: 2022-02-01
      Issue No: Vol. 25, No. 1 (2022)
  • Management of asymptomatic hyperuricemia in chronic kidney disease: A
           proposed stepwise approach

    • Authors: Mohammed Abdel Gawad, Dina Zaki, Anass Qasem
      Pages: 8 - 13
      Abstract: Serum uric acid levels are frequently elevated in patients with chronic kidney disease (CKD). The relatively modest hyperuricaemia in CKD may reflect the reduced efficiency of renal excretion of urate. In the past two decades, basic research has shown that hyperuricaemia plays a causal role in the progression of CKD through direct renal injury. However, clinical studies have reported conflicting results, hence there is much controversy about the scope of treating asymptomatic hyperuricaemia to prevent or reduce the rate of CKD progression. In this review, we highlight the most recent guidelines and clinical trials that tested the use of urate-lowering therapy in the management of asymptomatic hyperuricaemia in CKD patients.
      PubDate: 2022-03-04
      Issue No: Vol. 25, No. 1 (2022)
  • Knowledge of medical specialists on the emergency management of
           hyperkalaemia with a focus on insulin-based therapy

    • Authors: Mogamat-Yazied Chothia, Usuf Chikte, Mogamat Razeen Davids
      Pages: 14 - 25
      Abstract: Introduction: Hyperkalaemia is a common electrolyte disorder in hospitalised patients and may cause life-threatening cardiac arrythmias and death. There is a lack of consensus regarding its optimal management, which may result in wide variations in practice and the guidance provided to junior staff. Methods: We conducted a survey on a Research Electronic Data Capture (REDCap) platform to evaluate the knowledge of medical specialists regarding the diagnosis and management of hyperkalaemia, with a focus on insulinbased therapy. A convenience sample of 70 specialists in nephrology, internal medicine, emergency medicine and critical-care medicine were invited to participate. Comparisons were also made between nephrologists and nonnephrologists. Results: A total of 51 medical specialists responded, of whom 47% were nephrologists. They were more likely to initiate therapy at a potassium concentration ([K]) of 6 mmol/L, whereas non-nephrologists tended to start at a lower concentration (P < 0.01). Half the respondents regarded blood gas machine measurements as providing an accurate measure of [K]. Non-nephrologists were more likely to perform an ECG before starting treatment (P = 0.02). All respondents regarded insulin and dextrose as the most effective and reliable means for shifting K. Only 22% monitored the serum glucose concentration beyond 2 hours following insulin-based therapy, and 22% thought that hypoglycaemia was an uncommon complication if dextrose also was administered. Conclusions: This is the first comprehensive survey to report on the knowledge of specialists regarding the emergency management of hyperkalaemia. There is a need to address knowledge gaps, particularly around the optimal and safe use of insulin-based therapies. Our findings and recommendations should be useful in informing the development of consensus guidelines and educational resources on hyperkalaemia.  
      PubDate: 2022-03-09
      Issue No: Vol. 25, No. 1 (2022)
  • Effect of diuretics on kidney stone-forming risk – an investigation
           using multiple timed urine collections

    • Authors: Julia Morley, Megan Rensburg, Mariza Hoffman, Mogamat Shafick Hassan, Mogamat Razeen Davids
      Pages: 26 - 34
      Abstract: Introduction: Thiazide diuretics can lower urinary calcium excretion, helping to prevent recurrent calcium kidney stones. As dietary intake and urine chemistry varies throughout the day, a 24-h urine collection may not provide sufficient information to guide the optimal management in individual patients. Using multiple timed urine collections, we sought to identify times during the day when stone-forming risk is higher, allowing for therapy to be more accurately targeted. Methods: In a prospective study, healthy adult volunteers took a 4-week course of either hydrochlorothiazide (HCTZ) 25 mg/d or indapamide 2.5 mg/d. They were assessed at baseline, and at days 7, 14 and 28. At each time point, blood samples were taken for analysis and multiple timed urine samples were collected throughout the day, together with one overnight sample. Results: Diuretic treatment was well tolerated. Daily calcium and citrate excretion decreased, while ionized calcium and phosphate excretion were unchanged. Ionized calcium-divalent phosphate and ionized calcium-oxalate products were unchanged. In the timed urine samples, calcium excretion was decreased, particularly by indapamide, in the morning. Indapamide, but not HCTZ, decreased urinary citrate excretion, most obviously in overnight and early morning urines. No changes in ionized calcium were observed. Decreased divalent phosphate excretion was observed at several time points in the indapamide group. The ionized calcium-divalent phosphate product tended to decrease at most time points in both groups but no significant changes were observed in the ionized calcium-oxalate product. Conclusions: Indapamide 2.5 mg/d has a stronger protective effect against forming calcium kidney stones than HCTZ 25 mg/d. Most of the benefits appear to be achieved during the daytime and it may therefore be beneficial to prescribe medication twice daily or in the evening to maximize the protective effects of these agents. The benefits of indapamide treatment were attenuated by a reduction in urinary citrate excretion, an effect which has not been previously described.
      PubDate: 2022-03-22
      Issue No: Vol. 25, No. 1 (2022)
  • Reduced glomerular filtration rate is associated with ascending aortic
           dilatation in South African chronic kidney disease patients

    • Authors: Muzamil Hassan, Ahmed Vachiat, Sacha Grinter, Pravin Manga, Raquel Duarte, Saraladevi Naicker
      Pages: 46 - 54
      Abstract: Background: Ascending aortic dilatation (AAD) is an adverse prognostic cardiovascular marker in the general population. There are few data reporting its presence or clinical significance in chronic kidney disease (CKD) patients. The aim of this study was to evaluate ascending aorta dimensions and their correlates in a population of South African CKD patients.
      Methods: A total of 124 CKD patients and 40 healthy controls were enrolled. Cardiac dimensions, systolic and diastolic function indices, and aortic root diameters were assessed by transthoracic echocardiography. The ascending aorta was measured at four levels (aortic annulus, sinuses of Valsalva, sino-tubular junction, and ascending aorta) and was normalised for body surface area. The prevalence of AAD was assessed in CKD patients compared with the control group.
      Results: In CKD patients, the ascending aorta dimension was significantly larger than in controls at all four sites of the aorta that were measured. The prevalence of AAD was 6.5% at the annulus, 12.9% at the sinuses, 15.3% at the sino-tubular junction, and 8.9% at the ascending aorta. Overall, 29 patients (23%) had AAD. On multivariate analyses, eGFR was independently associated with AAD (odds ratio 0.980; 95% confidence interval 0.965–0.996; P = 0.014).
      Conclusion: AAD is a common cardiovascular phenotype in South African CKD patients. Low eGFR was independently associated with AAD, suggesting a direct link between CKD and the development of AAD in South African CKD patients.
      PubDate: 2022-05-15
      Issue No: Vol. 25, No. 1 (2022)
  • Prevalence of peripheral arterial disease and association with
           cardiovascular risk factors in patients with end-stage kidney disease in a
           hospital in Nigeria

    • Authors: Sadiq Abu, Olalekan O Olatise, Stephen O Asaolu, Gloria Daniel, Bala Waziri
      Pages: 55 - 60
      Abstract: Introduction: Peripheral arterial disease (PAD) is not uncommon among patients with end-stage kidney disease (ESKD), but it is usually under-reported. Moreover, PAD is a strong independent risk factor for cardiovascular disease in persons with chronic kidney disease (CKD). The aim of this study was to evaluate the prevalence of PAD and its association with cardiovascular risk factors in Nigerian patients with ESKD. Methods: This was a retrospective investigation of 122 subjects with ESKD on haemodialysis (HD), who were worked up for renal transplantation at Zenith Medical and Kidney Centre in Gudu, Abuja, Nigeria from February 2020 to March 2021. Data were obtained from the electronic medical records of the hospital and included sex, age, body mass index, history of diabetes, hypertension (HTN), duration of CKD, length of dialysis, lipid profile and lower limb Doppler ultrasound. Cardiovascular risk, measured as atherogenic index (AI), was calculated using the formula log (TG/ HDL-C), where TG = triglyceride and HDL-C = high-density lipoprotein cholesterol. Data analysis was performed using SPSS version 20. Continuous variables were expressed using measures of central tendency whereas categorical variables were expressed as frequency (percentages). Bivariate analysis was used to establish association between each variable, PAD and AI. A chi-square test was used to examine the relationship between categorical variables; a P value <0.05 was considered statistically significant. Results: Male subjects accounted for 81.1% of the study population. The median duration of CKD was 8 months (range 1–96 months) and the mean duration of dialysis was 10 ± 1.1 months. HTN was the commonest comorbidity factor in these subjects with 98 (80%) hypertensive with a median duration of the condition of 5 years (range 1–32 years); diabetes mellitus (DM) accounted for 44 (36%) patients with a median duration of 15 years (range 1–36 years). The prevalence of PAD among patients with ESKD was 48.4%. AI was associated with dialysis duration. The association between duration of CKD and PAD was positive and significant (rho = –0.245, P = 0.007). Conclusion: PAD was highly prevalent among patients with ESKD and remains one of the most potent risk markers for cardiovascular morbidity in patients with CKD. Patients with CKD should routinely be examined for PAD and the longer ESKD patients stay on dialysis, the greater the risk of developing cardiovascular disease. Screening for PAD and prompt treatment would be beneficial for pretransplant patients before the procedure.
      PubDate: 2022-06-08
      Issue No: Vol. 25, No. 1 (2022)
  • COVID-19 vaccine hesitancy and response to a simple educational
           intervention in patients attending an outpatient dialysis unit in
           Johannesburg, South Africa

    • Authors: Zaheera Cassimjee, Malcolm Davies, Chandni Dayal, Sheetal Chiba
      Pages: 61 - 73
      Abstract: Background: Patients living with kidney failure are at risk of severe COVID-19 disease. However, vaccination reduces transmission and severity of disease. The uptake of COVID-19 vaccination in South Africa remains poor,  suggesting a requirement for novel recruitment strategies. We examined COVID-19 vaccine hesitancy in an urban dialysis population in Johannesburg, South Africa, and investigated the efficacy of an educational intervention on vaccination intention. Methods: One hundred and four participants were recruited from outpatient haemo- and peritoneal dialysis units at the Helen Joseph Hospital. Participants completed anonymous, self-administered questionnaires analysing their acceptance of and concerns regarding COVID-19 vaccination before and after dissemination of the South African Nephrology Society SARS-CoV-2 vaccine information brochure. Results: Seventy-two participants (69%) were unvaccinated against SARS-CoV-2; 23 (22%) indicated unwillingness to undergo vaccination. Vaccine side effects, safety and perceived risk of SARS-CoV-2  transmission by vaccination were important factors in hesitancy. A small proportion believed that COVID-19 was not a serious threat to personal health. News media was an important information source for vaccine-hesitant respondents; prior healthcare worker counselling reduced hesitancy (OR 0.175, 95% CI 0.039–0.784; P = 0.023). The information brochure reduced concerns about vaccine side effects (P = 0.028), increasing vaccination intention to 84%. In-centre vaccination was additionally identified as a strategy to reduce hesitancy (OR 0.053, 95% CI 0.012–0.221; P < 0.001). Conclusions: This first analysis in an urban dialysis population in South Africa highlights factors contributing to vaccine hesitancy. Simple educational interventions capitalising on trust in healthcare workers and improved vaccine accessibility may increase vaccine uptake.
      PubDate: 2022-05-25
      Issue No: Vol. 25, No. 1 (2022)
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Tel: +00 44 (0)131 4513762

Your IP address:
Home (Search)
About JournalTOCs
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-